{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:04:29Z","timestamp":1771916669688,"version":"3.50.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,19]],"date-time":"2013-01-19T00:00:00Z","timestamp":1358553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s11910-012-0333-0","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T07:33:20Z","timestamp":1358494400000},"source":"Crossref","is-referenced-by-count":14,"title":["Neuromuscular Disorders of Glycogen Metabolism"],"prefix":"10.1007","volume":"13","author":[{"given":"Elisabetta","family":"Gazzerro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni L.","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,19]]},"reference":[{"key":"333_CR1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1566524024605761","volume":"2","author":"PJ Roach","year":"2002","unstructured":"Roach PJ. Glycogen and its metabolism. Curr Mol Med. 2002;2:101\u201320.","journal-title":"Curr Mol Med"},{"key":"333_CR2","first-page":"96","volume":"30","author":"S DiMauro","year":"2011","unstructured":"DiMauro S, Spiegel R. Progress and problems in muscle glycogenoses. Acta Myol. 2011;30:96\u2013102.","journal-title":"Acta Myol"},{"key":"333_CR3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.siny.2011.04.010","volume":"16","author":"S DiMauro","year":"2011","unstructured":"DiMauro S, Garone C. Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the mitochondrial respiratory chain. Semin Fetal Neonatal Med. 2011;16:181\u20139.","journal-title":"Semin Fetal Neonatal Med"},{"key":"333_CR4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1042\/BJ20111416","volume":"441","author":"PJ Roach","year":"2012","unstructured":"Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS. Glycogen and its metabolism: some new developments and old themes. Biochem J. 2012;441:763\u201387.","journal-title":"Biochem J"},{"key":"333_CR5","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT Ploeg van der","year":"2008","unstructured":"van der Ploeg AT, Reuser AJ. Pompe's disease. Lancet. 2008;372:1342\u201353.","journal-title":"Lancet"},{"key":"333_CR6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa0900661","volume":"362","author":"AR Moslemi","year":"2010","unstructured":"Moslemi AR, Lindberg C, Nilsson J, et al. Glycogenin-1 deficiency and inactivated priming of glycogen synthesis. N Engl J Med. 2010;362:1203\u201310.","journal-title":"N Engl J Med"},{"key":"333_CR7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bbadis.2011.11.017","volume":"1822","author":"J Nilsson","year":"2012","unstructured":"Nilsson J, Halim A, Moslemi AR, et al. Molecular pathogenesis of a new glycogenosis caused by a glycogenin-1 mutation. Biochim Biophys Acta. 2012;1822:493\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"333_CR8","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa066691","volume":"357","author":"G Kollberg","year":"2007","unstructured":"Kollberg G, Tulinius M, Gilljam T, et al. Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0. N Engl J Med. 2007;357:1507\u201314.","journal-title":"N Engl J Med"},{"key":"333_CR9","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1128\/MCB.24.16.7179-7187.2004","volume":"24","author":"BA Pederson","year":"2004","unstructured":"Pederson BA, Chen H, Schroeder JM, et al. Abnormal cardiac development in the absence of heart glycogen. Mol Cell Biol. 2004;24:7179\u201387.","journal-title":"Mol Cell Biol"},{"key":"333_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1566524024605815","volume":"2","author":"SW Moses","year":"2002","unstructured":"Moses SW, Parvari R. The variable presentations of glycogen storage disease type IV: a review of clinical, enzymatic and molecular studies. Curr Mol Med. 2002;2:177\u201388.","journal-title":"Curr Mol Med"},{"key":"333_CR11","first-page":"75","volume":"26","author":"C Bruno","year":"2007","unstructured":"Bruno C, Cassandrini D, Assereto S, et al. Neuromuscular forms of glycogen branching enzyme deficiency. Acta Myol. 2007;26:75\u20138.","journal-title":"Acta Myol"},{"key":"333_CR12","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.humpath.2011.10.001","volume":"43","author":"PL Magoulas","year":"2012","unstructured":"Magoulas PL, El-Hattab AW, Roy A, et al. Diffuse reticuloendothelial system involvement in type IV glycogen storage disease with a novel GBE1 mutation: a case report and review. Hum Pathol. 2012;43:943\u201351.","journal-title":"Hum Pathol"},{"key":"333_CR13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1212\/01.WNL.0000138429.11433.0D","volume":"63","author":"C Bruno","year":"2004","unstructured":"Bruno C, van Diggelen OP, Cassandrini D, et al. Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV). Neurology. 2004;63:1053\u20138.","journal-title":"Neurology"},{"key":"333_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0387-7604(12)80277-4","volume":"14","author":"E Reusche","year":"1992","unstructured":"Reusche E, Aksu F, Goebel HH, et al. A mild juvenile variant of type IV glycogenosis. Brain Dev. 1992;14:36\u201343.","journal-title":"Brain Dev"},{"key":"333_CR15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-3476(87)80341-4","volume":"111","author":"S Servidei","year":"1987","unstructured":"Servidei S, Riepe RE, Langston C, et al. Severe cardiopathy in branching enzyme deficiency. J Pediatr. 1987;111:51\u2013516.","journal-title":"J Pediatr"},{"key":"333_CR16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00005072-199201000-00004","volume":"51","author":"HH Goebel","year":"1992","unstructured":"Goebel HH, Shin YS, Gullotta F, et al. Adult polyglucosan body myopathy. J Neuropathol Exp Neurol. 1992;51:24\u201335.","journal-title":"J Neuropathol Exp Neurol"},{"key":"333_CR17","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.410300505","volume":"30","author":"A Lossos","year":"1991","unstructured":"Lossos A, Barash V, Soffer D, et al. Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients. Ann Neurol. 1991;30:655\u201362.","journal-title":"Ann Neurol"},{"key":"333_CR18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ana.410330114","volume":"33","author":"C Bruno","year":"1993","unstructured":"Bruno C, Servidei S, Shanske S, et al. Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol. 1993;33:88\u201393.","journal-title":"Ann Neurol"},{"key":"333_CR19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.nmd.2010.07.275","volume":"20","author":"AL Taratuto","year":"2010","unstructured":"Taratuto AL, Akman HO, Saccoliti M, Riudavets M, Arakaki N, Mesa L, Sevlever G, Goebel H, DiMauro S. Branching enzyme deficiency\/glycogenosis storage disease type IV presenting as a severe congenital hypotonia: muscle biopsy and autopsy findings, biochemical and molecular genetic studies. Neuromuscul Disord. 2010;20:783\u201390.","journal-title":"Neuromuscul Disord"},{"key":"333_CR20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1203\/00006450-199212000-00020","volume":"32","author":"JC Fyfe","year":"1992","unstructured":"Fyfe JC, Giger U, Van Winkle TJ, et al. Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats. Pediatr Res. 1992;32:719\u201325.","journal-title":"Pediatr Res"},{"key":"333_CR21","first-page":"570","volume":"15","author":"TL Ward","year":"2004","unstructured":"Ward TL, Valberg SJ, Adelson DL, et al. Glycogen branching enzyme (GBE1) mutation causing equine glycogen storage disease IV. Mamm Genome. 2004;15:570\u20137.","journal-title":"Mamm Genome"},{"key":"333_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/hmg\/ddq492","volume":"20","author":"YC Lee","year":"2011","unstructured":"Lee YC, Chang CJ, Bali D, et al. Glycogen-branching enzyme deficiency leads to abnormal cardiac development: novel insights into glycogen storage disease IV. Hum Mol Genet. 2011;20:455\u201365.","journal-title":"Hum Mol Genet"},{"key":"333_CR23","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1093\/hmg\/ddr371","volume":"20","author":"HO Akman","year":"2011","unstructured":"Akman HO, Sheiko T, Tay SK, et al. Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV. Hum Mol Genet. 2011;20:4430\u20139.","journal-title":"Hum Mol Genet"},{"key":"333_CR24","unstructured":"\u2022 Goldstein J, Austin S, Kishnani P, Bali D. Phosphorylase kinase deficiency. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews\u2122 [Internet]. Seattle: University of Washington; 1993\u20132011 May 31. This is a comprehensive review of physiopathological and clinical features of glycogenosis type VIII."},{"key":"333_CR25","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1093\/hmg\/3.11.1983","volume":"3","author":"M Wehner","year":"1994","unstructured":"Wehner M, Clemens PR, Engel AG, Kilimann MW. Human muscle glycogenosis due to phosphorylase kinase deficiency associated with a nonsense mutation in the muscle isoform of the alpha subunit. Hum Mol Genet. 1994;3:1983\u20137.","journal-title":"Hum Mol Genet"},{"key":"333_CR26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1006\/bbrc.1998.9211","volume":"249","author":"C Bruno","year":"1998","unstructured":"Bruno C, Manfredi G, Andreu AL, et al. A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy. Biochem Biophys Res Commun. 1998;249:648\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"333_CR27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.ejhg.5200996","volume":"11","author":"B Burwinkel","year":"2003","unstructured":"Burwinkel B, Hu B, Schroers A, et al. Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases. Eur J Hum Genet. 2003;11:516\u201326.","journal-title":"Eur J Hum Genet"},{"key":"333_CR28","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.a.30517","volume":"133","author":"W Wuyts","year":"2005","unstructured":"Wuyts W, Reyniers E, Ceuterick C, Storm K, de Barsy T, Martin JJ. Myopathy and phosphorylase kinase deficiency caused by a mutation in the PHKA1 gene. Am J Med Genet A. 2005;133:82\u20134.","journal-title":"Am J Med Genet A"},{"key":"333_CR29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.nmd.2009.11.004","volume":"20","author":"A Echaniz-Laguna","year":"2010","unstructured":"Echaniz-Laguna A, Akman HO, et al. Muscle phosphorylase b kinase deficiency revisited. Neuromuscul Disord. 2010;20:125\u20137.","journal-title":"Neuromuscul Disord"},{"key":"333_CR30","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1212\/01.wnl.0000289190.66955.67","volume":"70","author":"MC \u00d8rngreen","year":"2008","unstructured":"\u00d8rngreen MC, Schelhaas HJ, Jeppesen TD, et al. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology. 2008;70:1876\u201382.","journal-title":"Neurology"},{"key":"333_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.0b013e31824365f9","volume":"78","author":"N Preisler","year":"2012","unstructured":"Preisler N, Orngreen MC, Echaniz-Laguna A, et al. Muscle phosphorylase kinase deficiency: a neutral metabolic variant or a disease? Neurology. 2012;78:265\u20138.","journal-title":"Neurology"},{"key":"333_CR32","unstructured":"Arenas J, Mart\u00edn MA, Andreu AL. Glycogen storage disease type V. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews\u2122 [Internet]. Seattle: University of Washington; 1993\u20132006 Apr 19 (updated 12 May 2009)."},{"key":"333_CR33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jnnp-2011-301593","volume":"83","author":"A Lucia","year":"2012","unstructured":"Lucia A, Ruiz JR, Santalla A, et al. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry. J Neurol Neurosurg Psychiatry. 2012;83:322\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"333_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/humu.20649","volume":"29","author":"G Nogales-Gadea","year":"2008","unstructured":"Nogales-Gadea G, Rubio JC, Fernandez-Cadenas I, et al. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat. 2008;29:277\u201383.","journal-title":"Hum Mutat"},{"key":"333_CR35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/humu.9434","volume":"27","author":"C Bruno","year":"2006","unstructured":"Bruno C, Cassandrini D, Martinuzzi A, et al. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Hum Mutat. 2006;27:718.","journal-title":"Hum Mutat"},{"key":"333_CR36","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","volume":"132","author":"J Vissing","year":"2009","unstructured":"Vissing J, Duno M, Schwartz M, Haller RG. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease. Brain. 2009;132:1545\u201352.","journal-title":"Brain"},{"key":"333_CR37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","volume":"81","author":"R Quinlivan","year":"2010","unstructured":"Quinlivan R, Buckley J, James M, et al. McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry. 2010;81:1182\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"333_CR38","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","volume":"59","author":"RG Haller","year":"2002","unstructured":"Haller RG, Vissing J. Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms. Arch Neurol. 2002;59:1395\u2013402.","journal-title":"Arch Neurol"},{"key":"333_CR39","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncpneuro0913","volume":"4","author":"A Lucia","year":"2008","unstructured":"\u2022 Lucia A, Nogales-Gadea G, Perez M, et al. McArdle disease: what do neurologists need to know? Nat Clin Pract Neurol. 2008;4:568\u201377. This is a comprehensive review of clinical features and management aspects of glycogenosis type V.","journal-title":"Nat Clin Pract Neurol"},{"key":"333_CR40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/mus.880180710","volume":"18","author":"S Angelos","year":"1995","unstructured":"Angelos S, Valberg SJ, Smith BP, et al. Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related charolais cattle. Muscle Nerve. 1995;18:736\u201340.","journal-title":"Muscle Nerve"},{"key":"333_CR41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0960-8966(97)00062-X","volume":"7","author":"P Tan","year":"1997","unstructured":"Tan P, Allen JG, Wilton SD, et al. A splice-site mutation causing ovine McArdle's disease. Neuromuscul Disord. 1997;7:336\u201342.","journal-title":"Neuromuscul Disord"},{"key":"333_CR42","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/brain\/aws141","volume":"135","author":"G Nogales-Gadea","year":"2012","unstructured":"Nogales-Gadea G, Pin\u00f3s T, Lucia A, et al. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease. Brain. 2012;135:2048\u201357.","journal-title":"Brain"},{"key":"333_CR43","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","volume":"12","author":"PS Kishnani","year":"2010","unstructured":"\u2022 Kishnani PS, Austin SL, Arn P, et al. Glycogen storage disease type III diagnosis and management guidelines. Genet Med. 2010;12:446\u201363. This is a comprehensive review of physiopathological and clinical features of glycogenosis type III.","journal-title":"Genet Med"},{"key":"333_CR44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/GIM.0b013e3181d94eaa","volume":"12","author":"JL Goldstein","year":"2010","unstructured":"Goldstein JL, Austin SL, Boyette K, et al. Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with glycogen storage disease type III. Genet Med. 2010;12:424\u201330.","journal-title":"Genet Med"},{"key":"333_CR45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/GIM.0b013e3181e0e979","volume":"12","author":"SM Vertilus","year":"2010","unstructured":"Vertilus SM, Austin SL, Foster KS, et al. Echocardiographic manifestations of glycogen storage disease III: increase in wall thickness and left ventricular mass over time. Genet Med. 2010;12:413\u201323.","journal-title":"Genet Med"},{"key":"333_CR46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1939-1676.2007.tb02926.x","volume":"21","author":"BL Gregory","year":"2007","unstructured":"Gregory BL, Shelton GD, Bali DS, Chen YT, Fyfe JC. Glycogen storage disease type IIIa in curly-coated retrievers. J Vet Intern Med. 2007;21:40\u20136.","journal-title":"J Vet Intern Med"},{"key":"333_CR47","doi-asserted-by":"crossref","unstructured":"Yi H, Thurberg BL, Curtis S, et al. Characterization of a canine model of glycogen storage disease type IIIa. Dis Model Mech. 2012;5:804\u201311.","DOI":"10.1242\/dmm.009712"},{"key":"333_CR48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1566524024605734","volume":"2","author":"H Nakajima","year":"2002","unstructured":"Nakajima H, Raben N, Hamaguchi T, Yamasaki T. Phosphofructokinase deficiency; past, present and future. Curr Mol Med. 2002;2:197\u2013212.","journal-title":"Curr Mol Med"},{"key":"333_CR49","first-page":"105","volume":"26","author":"A Toscano","year":"2007","unstructured":"Toscano A, Musumeci O. Tarui disease and distal glycogenoses: clinical and genetic update. Acta Myol. 2007;26:105\u20137.","journal-title":"Acta Myol"},{"issue":"1","key":"333_CR50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.62.1.82","volume":"62","author":"RG Haller","year":"2004","unstructured":"Haller RG, Vissing J. No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology. 2004;62(1):82\u20136.","journal-title":"Neurology"},{"key":"333_CR51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nmd.2011.10.022","volume":"22","author":"O Musumeci","year":"2012","unstructured":"Musumeci O, Bruno C, Mongini T, et al. Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). Neuromuscul Disord. 2012;22:325\u201330.","journal-title":"Neuromuscul Disord"},{"key":"333_CR52","doi-asserted-by":"crossref","first-page":"e1000615","DOI":"10.1371\/journal.pgen.1000615","volume":"5","author":"M Garc\u00eda","year":"2009","unstructured":"Garc\u00eda M, Pujol A, Ruzo A, et al. Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis. PLoS Genet. 2009;5:e1000615.","journal-title":"PLoS Genet"},{"key":"333_CR53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2006.06351.x","volume":"136","author":"E Beutler","year":"2007","unstructured":"Beutler E. PGK deficiency. Br J Haematol. 2007;136:3\u201311.","journal-title":"Br J Haematol"},{"key":"333_CR54","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.nmd.2008.12.004","volume":"19","author":"R Spiegel","year":"2009","unstructured":"Spiegel R, Area Gomez E, Akman HO, et al. Myopathic form of phosphoglycerate kinase (PGK) deficiency: a new case and pathogenic considerations. Neuromusc Disord. 2009;19:207\u201311.","journal-title":"Neuromusc Disord"},{"key":"333_CR55","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/mus.21612","volume":"41","author":"E Sotiriou","year":"2010","unstructured":"Sotiriou E, Greene P, Krishna S, et al. Myopathy and parkinsonism in phosphoglycerate kinase deficiency. Muscle Nerve. 2010;41:707\u201310.","journal-title":"Muscle Nerve"},{"key":"333_CR56","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archneurol.2008.584","volume":"66","author":"A Naini","year":"2009","unstructured":"Naini A, Toscano A, Musumeci O, et al. Muscle phosphoglycerate mutase deficiency revisited. Arch Neurol. 2009;66:394\u20138.","journal-title":"Arch Neurol"},{"key":"333_CR57","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/mus.880181413","volume":"3","author":"T Kanno","year":"1995","unstructured":"Kanno T, Maekawa M. Lactate dehydrogenase M-subunit deficiencies: clinical features, metabolic background, and genetic heterogeneities. Muscle Nerve. 1995;3:S54\u201360.","journal-title":"Muscle Nerve"},{"key":"333_CR58","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1056\/NEJM199604253341705","volume":"334","author":"J Kreuder","year":"1996","unstructured":"Kreuder J, Borkhardt A, Repp R, et al. Inherited metabolic myopathy and hemolysis due to a mutation in aldolase a. N Engl J Med. 1996;334:1100\u20134.","journal-title":"N Engl J Med"},{"key":"333_CR59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.1095","volume":"50","author":"GP Comi","year":"2001","unstructured":"Comi GP, Fortunato F, Lucchiari S, et al. Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis. Ann Neurol. 2001;50:202\u20137.","journal-title":"Ann Neurol"},{"key":"333_CR60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1056\/NEJMc0901158","volume":"361","author":"T Stojkovic","year":"2009","unstructured":"\u2022\u2022 Stojkovic T, Vissing J, Petit F, et al. Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med. 2009;361:425\u20137. The is the first description of this new glycogen disorder.","journal-title":"N Engl J Med"},{"key":"333_CR61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s11910-007-0066-7","volume":"7","author":"AV Delgado-Escueta","year":"2007","unstructured":"Delgado-Escueta AV. Advances in Lafora progressive myoclonus epilepsy. Curr Neurol Neurosci Rep. 2007;7:428\u201333.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"333_CR62","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","volume":"20","author":"BA Minassian","year":"1998","unstructured":"Minassian BA, Lee JR, Herbrick JA, et al. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet. 1998;20:171\u20134.","journal-title":"Nat Genet"},{"key":"333_CR63","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nn1998","volume":"10","author":"D Vilchez","year":"2007","unstructured":"Vilchez D, Ros S, Cifuentes D, et al. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci. 2007;10:1407\u201313.","journal-title":"Nat Neurosci"},{"key":"333_CR64","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","volume":"285","author":"AA DePaoli-Roach","year":"2010","unstructured":"DePaoli-Roach AA, Tagliabracci VS, Segvich DM, et al. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin. J Biol Chem. 2010;285:25372\u201381.","journal-title":"J Biol Chem"},{"key":"333_CR65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ana.22156","volume":"68","author":"J Turnbull","year":"2010","unstructured":"\u2022 Turnbull J, Wang P, Girard JM, et al. Glycogen hyperphosphorylation underlies Lafora body formation. Ann Neurol. 2010;68:925\u201333. This article defines the relevance of glycogen phosphate accumulation in a mouse model of malin deficiency.","journal-title":"Ann Neurol"},{"key":"333_CR66","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Sakamoto T, et al. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet. 2002;11:1251\u201362.","journal-title":"Hum Mol Genet"},{"key":"333_CR67","doi-asserted-by":"crossref","first-page":"19262","DOI":"10.1073\/pnas.0707952104","volume":"104","author":"VS Tagliabracci","year":"2007","unstructured":"\u2022 Tagliabracci VS, Turnbull J, Wang W, et al. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc Natl Acad Sci USA. 2007;104:19262\u20136. This article defines the relevance of glycogen phosphate accumulation in a mouse model of laforin deficiency.","journal-title":"Proc Natl Acad Sci USA"},{"key":"333_CR68","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4161\/auto.8.2.19010","volume":"8","author":"R Puri","year":"2012","unstructured":"Puri R, Ganesh S. Autophagy defects in Lafora disease: cause or consequence? Autophagy. 2012;8:289\u201390.","journal-title":"Autophagy"},{"key":"333_CR69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1212\/WNL.0b013e31825dcea6","volume":"79","author":"AV Delgado-Escueta","year":"2012","unstructured":"Delgado-Escueta AV. Lafora progressive myoclonus epilepsy: glycogen storage disease vs neurodegenerative disease. Neurology. 2012;79:21\u20132.","journal-title":"Neurology"},{"key":"333_CR70","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","volume":"25","author":"DG Hardie","year":"2011","unstructured":"Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011;25:1895\u2013908.","journal-title":"Genes Dev"},{"key":"333_CR71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/jmbi.2001.5316","volume":"317","author":"JW Scott","year":"2002","unstructured":"Scott JW, Norman DG, Hawley SA, Kontogiannis L, Hardie DG. Protein kinase substrate recognition studied using the recombinant catalytic domain of AMP-activated protein kinase and a model substrate. J Mol Biol. 2002;317:309\u201323.","journal-title":"J Mol Biol"},{"key":"333_CR72","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","volume":"109","author":"M Arad","year":"2002","unstructured":"Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest. 2002;109:357\u201362.","journal-title":"J Clin Invest"},{"key":"333_CR73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1203\/PDR.0b013e3181462b86","volume":"62","author":"HO Akman","year":"2007","unstructured":"Akman HO, Sampayo JN, Ross FA, et al. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. Pediatr Res. 2007;62:499\u2013504.","journal-title":"Pediatr Res"},{"key":"333_CR74","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.0000075270.13497.2B","volume":"107","author":"M Arad","year":"2003","unstructured":"Arad M, Moskowitz IP, Patel VV, et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-white syndrome in glycogen storage cardiomyopathy. Circulation. 2003;107:2850\u20136.","journal-title":"Circulation"},{"key":"333_CR75","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1371\/journal.pone.0000903","volume":"2","author":"SR Costford","year":"2007","unstructured":"Costford SR, Kavaslar N, Ahituv N, et al. Gain-of-function R225W mutation in human AMPKgamma(3) causing increased glycogen and decreased triglyceride in skeletal muscle. PLoS One. 2007;2:e903.","journal-title":"PLoS One"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0333-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-012-0333-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0333-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T17:42:33Z","timestamp":1595266953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-012-0333-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,19]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1007\/s11910-012-0333-0","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,19]]},"article-number":"333"}}